FORMELA JEAN FRANCOIS

NTLA

FORMELA JEAN FRANCOIS serves as director at Intellia Therapeutics, Inc. (NTLA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$2.00M

Total Sells

9 trades

$125.37M

Net Position

Net Seller

$123.37M

Companies Traded

KRRO, IMA, NTLA

Active Period

Apr 2021 – Jul 2026

10 total trades

Most Recent

Sell KRRO

Jul 7, 2026 · $1.54M

FORMELA JEAN FRANCOIS's Insider Trading at Intellia Therapeutics, Inc. (NTLA)

Buys

0 · $0.00

Sells

5 · $120.94M

Total Shares Bought

Total Shares Sold

1,103,376

NTLA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 29, 2021	Sell	553,376	$132.73	$73.45M	537,357
Jun 15, 2021	Sell	201,725	$87.04	$17.56M	736,030
Apr 30, 2021	Sell	4,513	$85.43	$385.5K	765,101
Apr 28, 2021	Sell	342,962	$85.96	$29.48M	1,111,770
Apr 7, 2021	Sell	800	$84.98	$68.0K	1,112,576

FORMELA JEAN FRANCOIS's Insider Trading at Korro Bio, Inc. (KRRO)

Buys

0 · $0.00

Sells

3 · $4.04M

Total Shares Bought

Total Shares Sold

284,288

KRRO Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 7, 2026	Sell	110,023	$14.02	$1.54M	707,373
Jun 24, 2026	Sell	171,405	$14.34	$2.46M	936,252
Jun 1, 2026	Sell	2,860	$13.95	$39.9K	939,634

FORMELA JEAN FRANCOIS's Insider Trading at ImageneBio Inc (IMA)

Buys

1 · $2.00M

Sells

1 · $385.6K

Total Shares Bought

125,000

Total Shares Sold

26,278

IMA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 14, 2021	Buy	125,000	$16.00	$2.00M	874,634
Dec 14, 2021	Sell	26,278	$14.67	$385.6K	1,256,224

Related Insiders

Edward J Dulac III

officer: EVP, Chief Financial Officer

NTLASell · Jul 6, 2026

Michael P Dube

VP, Chief Accounting Officer

NTLASell · Jul 6, 2026

Vincent Loic A

officer: Chief Scientific Officer

KRROSell · Jun 17, 2026

Jeffrey Cerio

officer: General Counsel

KRROSell · Jun 17, 2026

Oliver Dolan

officer: Senior Vice President, Finance

KRROSell · Jun 17, 2026

Todd Chappell

officer: Chief Operating Officer

KRROSell · Jun 17, 2026

Ram Aiyar

director, officer: President and CEO

KRROSell · Jun 2, 2026

Lynx1 Capital Management LP

10 percent owner

KRROBuy · Apr 2, 2026

Explore More Insider Trading Data

NTLA Insider Trading Activity

View all insider trades at Intellia Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity